Log in to save to my catalogue

Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer a...

Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer a...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2727916002

Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and in vivo studies

About this item

Full title

Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and in vivo studies

Publisher

England: Taylor & Francis

Journal title

Journal of enzyme inhibition and medicinal chemistry, 2022-12, Vol.37 (1), p.299-314

Language

English

Formats

Publication information

Publisher

England: Taylor & Francis

More information

Scope and Contents

Contents

This research presents the design and synthesis of a novel series of phthalazine derivatives as Topo II inhibitors, DNA intercalators, and cytotoxic agents. In vitro testing of the new compounds against HepG-2, MCF-7, and HCT-116 cell lines confirmed their potent cytotoxic activity with low IC
50
values. Topo II inhibition and DNA intercalati...

Alternative Titles

Full title

Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and in vivo studies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2727916002

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2727916002

Other Identifiers

ISSN

1475-6366

E-ISSN

1475-6374

DOI

10.1080/14756366.2021.2007905

How to access this item